Literature DB >> 32093834

Large crystal growth for neutron protein crystallography.

Monika Budayova-Spano1, Katarina Koruza2, Zoë Fisher3.   

Abstract

The use of neutron protein crystallography (NPX) is expanding rapidly, with most structures determined in the last decade. This growth is stimulated by a number of developments, spanning from the building of new NPX beamlines to the availability of improved software for structure refinement. The main bottleneck preventing structural biologists from adding NPX to the suite of methods commonly used is the large volume of the individual crystals required for a successful experiment. A survey of deposited NPX structures in the Protein Data Bank shows that about two-thirds came from crystals prepared using vapor diffusion, while batch and dialysis-based methods all-together contribute to most of the remaining one-third. This chapter explains the underlying principles of these protein crystallization methods and provides practical examples that may help others to successfully prepare large crystals for NPX.
© 2020 Elsevier Inc. All rights reserved.

Keywords:  Dialysis; Microseeding; Phase diagram; Vapor diffusion

Mesh:

Substances:

Year:  2020        PMID: 32093834     DOI: 10.1016/bs.mie.2019.11.015

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

1.  Current status of neutron crystallography in structural biology.

Authors:  Fumiaki Kono; Kazuo Kurihara; Taro Tamada
Journal:  Biophys Physicobiol       Date:  2022-04-01

2.  Semi-empirical model to estimate ideal conditions for the growth of large protein crystals.

Authors:  Hirohiko Nakamura; Sachiko Takahashi; Koji Inaka; Hiroaki Tanaka
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-11-26       Impact factor: 7.652

3.  Room-temperature neutron and X-ray data collection of 3CL Mpro from SARS-CoV-2.

Authors:  Daniel W Kneller; Gwyndalyn Phillips; Andrey Kovalevsky; Leighton Coates
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-09-15       Impact factor: 1.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.